Probiotics for Disease Prevention: A Focus on Ventilator-Associated Pneumonia

Abstract

Spanish

French

Objective:

To summarize published data regarding the safety and efficacy of probiotics in the prevention of ventilator-associated pneumonia (VAP).

Data Sources:

PubMed databases (January 2000-August 2011) were searched and a bibliographic review of published articles was performed to identify original reports of probiotic administration for the prevention of VAP using the search terms probiotics, synbiotics, and ventilator-associated pneumonia.

Study Selection and Data Extraction:

Two pilot studies, 2 randomized controlled trials (RCTs), and 1 meta-analysis have addressed probiotic use for VAP prevention and were included in the review.

Data Synthesis:

VAP frequently occurs in mechanically ventilated patients. Given the lack of new antimicrobial agents, probiotics have been studied for their ability to modify human microflora colonization. Two studies examining pathogen colonization rates favored probiotics, with reduced incidence and increased duration until the emergence of new species. One prospective RCT found significant reduction in the incidence of VAP and colonization rates, but no significant difference in patient disposition outcomes. Another RCT examining 28-day mortality found no overall benefit with probiotic use and no reduction in colonization rates.

Conclusions:

Clinical trials have failed to demonstrate a consistent beneficial effect of probiotics in mechanically ventilated patients; thus, they are not recommended for routine clinical use. However, heterogeneity among study designs may hinder this assessment and the designs should be unified in future research.

Keywords

probiotics ventilator-associated pneumonia

References

American Thoracic Society: Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.

Fagon

, Chastre

, Hance

, Montravers

, Novara

, Gibert

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281–8.

Heyland

, Cook

, Griffith

, Keenan

, Brun-Buisson

The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159:1249–56.

Bercault

, Boulain

Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001;29:2303–9.

Craven

, De Rosa

, Thornton

Nosocomial pneumonia: emerging concepts in diagnosis, management, and prophylaxis. Curr Opin Crit Care 2002;8:421–9.

Relio

, Ollendorf

, Oster

. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115–21.

Kollef

, Shorr

, Tabak

, Gupta

, Liu

, Johannes

. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854–62.

Tejerina

, Frutos-Vivar

, Restrepo

. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 2006;21:56–65.

Bonten

. Healthcare epidemiology: ventilator-associated pneumonia: preventing the inevitable. Clin Infect Dis 2011;52:115–21.

10.

Coffin

, Klompas

, Classen

. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S31–40.

11.

Berra

, Sampson

, Fumagalli

, Panigada

, Kolobow

Alternative approaches to ventilator-associated pneumonia prevention. Minerva Anestesiol 2011;77:323–33.

12.

Klompas

Prevention of ventilator-associated pneumonia. Expert Rev Anti Infect Ther 2010;8:791–800.

13.

Safdar

, Crnich

, Maki

. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005;50:725–41.

14.

FAO/WHO. 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAOAVHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30-May 1, 2002.

15.

Forestier

, Guelon

, Cluytens

, Gillart

, Sirot

, De Champs

Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care 2008;12:R69.

16.

Klarin

, Molin

, Jeppsson

, Larsson

Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care 2008; 12:R 136.

17.

Chastre

, Fagon

. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867–903.

18.

Koenig

, Truwit

. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 2006;19:637–57.

19.

Vanderhoof

, Young

Probiotics in the United States. Clin Infect Dis 2008;46(suppl 2):S67–72.

20.

Williams

. Probiotics. Am J Health Syst Pharm 2010;67:449–58.

21.

Boyle

, Robins-Browne

, Tang

. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 2006;83:1256–64.

22.

Sanders

. Use of probiotics and yogurts in maintenance of health. J Clin Gastroenterol 2008;42(suppl 2):S71–4.

23.

Senok

, Ismaeel

, Botta

. Probiotics: facts and myths. Clin Microbiol Infect 2005; 11:958–66.

24.

Reid

, Jass

, Sebulsky

, McCormick

. Potential uses of probiotics in clinical practice. Clin Micobiol Rev 2003;16:658–672.

25.

Isakow

, Morrow

, Kollef

. Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest 2007;132:286–94.

26.

McNabb

, Isakow

Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. Curr Opin Pulm Med. 2008;14:169–75.

27.

, Hart

, Kamm

, Stagg

, Knight

. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 2009;15:300–10.

28.

Perdigón

, Maldonado Galdeano

, Valdez

, Medici

Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002; 56:S21–6.

29.

Vitiñi

, Alvarez

, Medina

, Medici

, de Budeguer

, Perdigón

Gut mucosal immunostimulation by lactic acid bacteria. Biocell 2000;24: 223–32.

30.

Alberda

, Gramlich

, Meddings

. Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007;85:816–23.

31.

Jain

, McNaught

, Anderson

, MacFie

, Mitchell

. Influence of symbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomized controlled trial. Clin Nutr 2004;23:467–75.

32.

Kotzampassi

, Giamarellos-Bourboulis

, Voudouris

, Kazamias

, Eleftheriadis

Benefits of a synbiotic formula (Synbiotic 2000 Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 2006;30:1848–55.

33.

Spindler-Vesel

, Bengmark

, Vovk

, Cerovic

, Kompan

Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Patenter Enteral Nutr 2007;31: 119–26.

34.

Rayes

, Seehofer

, Hansen

. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002;71:123–7.

35.

Watkinson

, Barber

, Dark

, Young

. The use of prepro- and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr 2007;26:182–92.

36.

Morrow

. Probiotics in the intensive care unit. Curr Opin Crit Care 2009;15:144–8.

37.

Hojsak

, Abdovic

, Szajewska

, Milosević

, Krznarić

, Kolacek

Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 2010;125:1171–7.

38.

Forestier

, Guelon

, Cluytens

, Gillart

, Sirot

, De Champs

Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care 2008;12:R69.

39.

Klarin

, Molin

, Jeppsson

, Larsson

Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care 2008; 12:R 136.

40.

Knight

, Gardiner

, Banks

. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomized, double-blind, placebo-controlled trial. Intensive Care Med 2009; 35:854–61.

41.

Morrow

, Kollef

, Casale

. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010;182:1058–64.

42.

Barraud

, Blard

, Hein

. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 2010;36:1540–7.

43.

Besselink

, van Santvoort

, Buskens

. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:651–9.

44.

Siempos

, Ntaidow

, Falagas

. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a metaanalysis of randomized controlled trials. Crit Care Med 2010;38:954–62.

45.

Liong

. Safety of probiotics: translocation and infection. Nutr Rev 2008;66:192–202.

46.

Weese

. Evaluation of deficiencies in labeling of commercial probiotics. Can Vet J 2003;44:982–3.

47.

Hamilton-Miller

, Shah

, Winkler

. Public health issues arising from microbiological and labeling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr 1999;2:334–9.

48.

Snydman

. The safety of probiotics. Clin Infect Dis 2008;46(suppl 2):S104–11.

49.

Zhou

, Shu

, Rutherford

. Safety assessment of potential probiotic lactic acid bacteria strains Lactobacillus rhamnosus HN001.Lb. acidophilus HN017 and Bifidobacterium lactis HN019 in BALB/c mice. Int J Food Microbiol 2000;56:87–96.

50.

Asahara

, Takahashi

, Nomoto

. Assessment of safety of Lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol 2003;10:169–73.

51.

Berg

, Garlington

. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in the gnotobiotic mouse model. Infect Immun 1979;23:401–11.